The rapid increase in the use of glucagon-like peptide-1 receptor agonists for weight loss, diabetes management and ...

Topline data were announced from a phase 3 trial evaluating setmelanotide for the treatment of acquired hypothalamic obesity.

What is the market capitalization of NIFTY200 VALUE 30 INDEX? What is the 52 wk high/low for NIFTY200 VALUE 30 INDEX?

FTSE 100 Index 8,249.12 114.78 1.41% ...

Fortinet Inc. $99.20 2.35 2.43% ...